News

Mr Conta comes to Cardiac Dimensions from Spiration, a medical device company. Prior to Spiration, he ran R&D operations for Spinal Dynamics, Wright Medical Technology, Joint Medical Products

In this randomized, placebo-controlled Phase II trial the effect of Elafin on inflammatory parameters will be investigated in patients undergoing esophagectomy for esophagus carcinoma. The trial will be

As part of the acquisition, Sequenom has formalized certain collaborative agreements with Spectrum Health and the Van Andel Research Institute, which were joint venture partners in the Clinical

Gentamicin surgical implant is currently being evaluated in two Phase III clinical trials as an adjunct to systemic antibiotic administration for the prevention of surgical site infections in

Dr Jones previously led the pharma business unit for Devgen in Ghent, Belgium. Prior to that, he was vice president of business development at BioRexis Pharmaceuticals. Most recently,

Cenix will apply InteRNA’s lentiviral-based miRNA overexpression library in high throughput screening assays in combination with high content, multi-parametric phenotypic analyses to identify the biological role of individual

Victory pacemakers are designed to promote more natural heart function, allowing the patient’s own heart rhythm to prevail when possible by reducing the device’s ventricular pacing using ‘smart

Ms Davis brings to the company her strong business drive and diversified experience as a CFO. Her background includes a BS in business administration from California State University,

This sixth site is in addition to Sydney, Brisbane and Adelaide in Australia, as well as MD Anderson in Houston, Texas, and St Luke’s Hospital & Health Network,